Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Evolving First-Line Treatment Strategies in ERBB2-Positive Metastatic Breast Cancer: A Review.

Importance The treatment landscape of ERBB2 (formerly HER2)-positive metastatic breast cancer has evolved substantially during the past decade, with emerging therapies challenging the long-standing induction-maintenance paradigm established by the CLEOPATRA trial (NCT00567190). However, optimal treatment selection, seq...

Yu Zong, L. Carey, Y. Abdou · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.